2nd Quarter - Report

HOLLAND & KNIGHT LLP for ALLIANCE FOR REGENERATIVE MEDICINE

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocate for creation of national strategy for regenerative medicine. Lobbied in support of legislation that would establish the national strategy, including a GAO report and federal policy coordination, which became S.2126, the Representative Medicare Promotion Act. Also worked with White House on "Grand Challenge." Also lobbied regarding H.R. 4800/S.2389, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015.

LobbyistCovered position, as disclosed
LISA A BARKOVIC —
RIDGE BLANCHARD —
ANDREW CONLIN —
MIRANDA FRANCO —
DAVID HARRY MANN New —
PETER CHALMERS ORMEROD New —
MICHAEL WERNER —

Contacted: Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2126 (113th), H.R. 4800 (113th), S. 2389 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.